Investor Relations February 28, 2025 Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval Read More
Investor Relations February 26, 2025 Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board Read More
Videos February 19, 2025 Inside Nexalin: CEO Mark White on TBI Solutions & Expanding Market Potential Read More
Investor Relations February 10, 2025 Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition Read More
Investor Relations February 3, 2025 Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study Read More
Investor Relations January 23, 2025 Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23 Read More
